Lupin Digital Health, a fully-owned unit of the global pharmaceutical powerhouse Lupin Limited, has unveiled a pioneering alliance with Medicover Hospitals. This transformative collaboration aims to deliver top-tier post-surgical rehabilitation and care for Medicover’s cardiac patients, ushering in a new era in cardiac care across India. The collaboration focuses on home-based rehabilitation, supported by advanced digital therapeutic solutions.
Medicover Hospitals, a major European healthcare provider with a substantial footprint in India, selected Lupin Digital Health’s leading-edge Digital Therapeutics (DTx) solution, Lyfe, to bolster its cardiac care offerings. This partnership is set to ensure continuous care for patients following cardiac procedures, reinforcing monitoring and adherence to treatment protocols.
Recognized as a Class C Medical Device by the CDSCO, Government of India, Lyfe promises stronger patient engagement with healthcare teams, ultimately enhancing health results for Medicover’s clientele.
Rajeev Sibal, President of India Region Formulations at Lupin, remarked, “Our collaboration with Medicover Hospitals marks a pivotal stride towards introducing sophisticated digital health solutions to cardiac patients across India. This will greatly enhance personalized care and patient recovery, ensuring better compliance with treatment plans.”
Sidharth Srinivasan, CEO of Lupin Digital Health, highlighted, “The phase following cardiac discharge has traditionally been challenging, with many patients experiencing gaps in care. Through this collaboration, Medicover has taken a monumental step to guarantee continuous support for patients all over India, tackling patient non-adherence.”
Dr. Sharath Reddy, Executive Director and Senior Interventional Cardiologist at Medicover Group of Hospitals, underscored the importance of this collaboration, stating, “Medicover is rapidly expanding as a multispecialty hospital chain in India, renowned for top-tier cardiac procedures using advanced imaging and surgical technologies to deliver high-quality care. With our partnership with LYFE from Lupin Digital Health, we aim to offer comprehensive cardiovascular care at home, addressing key challenges in post-discharge management.”
Medicover will extend these extensive cardiac care initiatives, powered by Lupin Digital Health, throughout its network of multispecialty hospitals.
Operating across 13 countries, Medicover is a globally esteemed healthcare brand, with a presence in Germany, Sweden, Poland, Turkey, and others, including India. Medicover Hospitals in India boasts a significant presence in Telangana, Andhra Pradesh, Maharashtra, and Karnataka, with 23 hospitals serving millions annually.
Lupin Digital Health, a wholly owned subsidiary of the leading global pharmaceutical firm Lupin Limited, is focused on creating pioneering digital health solutions to meet patient demands. Its flagship program, Lyfe, is a groundbreaking digital therapeutics tool employing AI and ML to deliver tailored and engaging patient experiences.